Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal serogroup C vaccine (Bio-Manguinhos)

Meningococcal serogroup C vaccine · Bio-Manguinhos/Fiocruz
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meningococcal serogroup C vaccine (Bio-Manguinhos), covering 2015-09-16 to 2015-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos [Phase 1]

See pricing